[Target validation strategy in designing novel therapeutics for schizophrenia].
Takao
T
Yoshimizu
Katsunori
K
Tajinda
D000818:Animals; D004195:Disease Models, Animal; D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics